| Business Name: |
Athenese Therapeutics |
| Contact Person: |
Bala Pandi |
| Address: |
10110 Mesa Rim Road, San Diego, California 92121 |
| Phone Number: |
(858) 245-2303 |
| Annual Revenue (USD): |
$100.000 to $499.999 |
| Founding Year: |
2011 |
| Location Type: |
Single Location |
| Employee Number: |
1 to 4 |
| Business Type: |
B2B (Business to Business) |
| Business Category: |
Biological Research |
| SIC Code: |
8731 |
| NAICS Code: |
541712 |
| Share This Business: |
|
| Related Businesses: |
Sequenom Inc - San Diego, CA 92121
Trovagene Inc - San Diego, CA 92121
Gen Probe Inc - San Diego, CA 92121
Samm Solutions Inc - San Diego, CA 92121
Otonomy Inc - San Diego, CA 92121
Organovo Holdings Inc - San Diego, CA 92121
Sequenom Inc - San Diego, CA 92121
Innovative Sewer Technologies - San Diego, CA 92121
Avantgen Inc - San Diego, CA 92121
Envoy Therapeutics Inc - San Diego, CA 92121
Jaden Bioscience Inc - San Diego, CA 92121
Amaratek - San Diego, CA 92121
Gensura Laboratories Inc - San Diego, CA 92121
Aqua Bounty Technologies - San Diego, CA 92121
Ither X Inc - San Diego, CA 92121
Alexis Corporation - San Diego, CA 92121
Vertex Pharmaceuticals Inc - San Diego, CA 92121
Ceregene Inc - San Diego, CA 92121
Imgenex Corp - San Diego, CA 92121
Stressgen Biotechnologies Inc - San Diego, CA 92121
|
The company Athenese Therapeutics provides B2B services in the form of Biological Research from its single location in California.
1 to 4 employees work for Athenese Therapeutics, and the business now earns $100.000 to $499.999 per annum.
Athenese Therapeutics was launched in 2011 and is classified under SIC code and category 8731 , and NAICS number and grouping 541712 .
To contact Athenese Therapeutics, please call Bala Pandi with the phone number (858) 245-2303 or visit its single location at 10110 Mesa Rim Road in San Diego, California 92121.
The location of the single location can also be found using the coordinates 32.903203,-117.177231.
Read more details about this business on the webpage or follow the company’s social media accounts, on Twitter and on Facebook.